Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2694-54-4
2. Triallyl Benzene-1,2,4-tricarboxylate
3. 1,2,4-benzenetricarboxylic Acid, Tri-2-propenyl Ester
4. Trimellitic Acid Triallyl Ester
5. 1,2,4-triallyl Trimellitate
6. Triallyl 1,2,4-benzenetricarboxylate
7. Tris(prop-2-enyl) Benzene-1,2,4-tricarboxylate
8. 4mjd3rl023
9. 1,2,4-benzenetricarboxylic Acid, 1,2,4-tri-2-propen-1-yl Ester
10. 1,2,4-benzenetricarboxylic Acid, Triallyl Ester
11. Triam 705
12. 1,2,4-benzenetricarboxylic Acid, 1,2,4-tri-2-propen-1-yl Ester, Homopolymer
13. 29323-03-3
14. Einecs 220-264-2
15. Unii-4mjd3rl023
16. Tri-2-propenyl 1,2,4-benzenetricarboxylate
17. Triallyl Trimellite
18. Dsstox_cid_24901
19. Dsstox_rid_80572
20. Dsstox_gsid_44901
21. Schembl48751
22. Chembl3185572
23. Dtxsid4044901
24. Caa69454
25. Zinc1841098
26. Tox21_301788
27. Mfcd00080653
28. Triallylbenzene-1,2,4-tricarboxylate
29. Akos024462350
30. Ds-7411
31. Ncgc00256258-01
32. Cas-2694-54-4
33. Db-025078
34. Cs-0157983
35. Ft-0688203
36. D82090
37. Q27260131
| Molecular Weight | 330.3 g/mol |
|---|---|
| Molecular Formula | C18H18O6 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 12 |
| Exact Mass | 330.11033829 g/mol |
| Monoisotopic Mass | 330.11033829 g/mol |
| Topological Polar Surface Area | 78.9 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 496 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Triallyl Trimellitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triallyl Trimellitate, including repackagers and relabelers. The FDA regulates Triallyl Trimellitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triallyl Trimellitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Triallyl Trimellitate supplier is an individual or a company that provides Triallyl Trimellitate active pharmaceutical ingredient (API) or Triallyl Trimellitate finished formulations upon request. The Triallyl Trimellitate suppliers may include Triallyl Trimellitate API manufacturers, exporters, distributors and traders.
click here to find a list of Triallyl Trimellitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Triallyl Trimellitate DMF (Drug Master File) is a document detailing the whole manufacturing process of Triallyl Trimellitate active pharmaceutical ingredient (API) in detail. Different forms of Triallyl Trimellitate DMFs exist exist since differing nations have different regulations, such as Triallyl Trimellitate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Triallyl Trimellitate DMF submitted to regulatory agencies in the US is known as a USDMF. Triallyl Trimellitate USDMF includes data on Triallyl Trimellitate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Triallyl Trimellitate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Triallyl Trimellitate suppliers with USDMF on PharmaCompass.
Triallyl Trimellitate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Triallyl Trimellitate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triallyl Trimellitate GMP manufacturer or Triallyl Trimellitate GMP API supplier for your needs.
A Triallyl Trimellitate CoA (Certificate of Analysis) is a formal document that attests to Triallyl Trimellitate's compliance with Triallyl Trimellitate specifications and serves as a tool for batch-level quality control.
Triallyl Trimellitate CoA mostly includes findings from lab analyses of a specific batch. For each Triallyl Trimellitate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Triallyl Trimellitate may be tested according to a variety of international standards, such as European Pharmacopoeia (Triallyl Trimellitate EP), Triallyl Trimellitate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triallyl Trimellitate USP).
LOOKING FOR A SUPPLIER?
